Page last updated: 2024-08-21

oxazoles and gw 409544

oxazoles has been researched along with gw 409544 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, JL; Gampe, RT; Kliewer, SA; Lambert, MH; McKee, DD; Montana, VG; Moore, JT; Moore, LB; Oplinger, JA; Plunket, KD; Willson, TM; Xu, HE1
Cobb, JE; Galardi, CM; Kliewer, SA; Lambert, MH; McKee, DD; Montana, VG; Moore, JT; Nolte, RT; Parks, DJ; Plunket, KD; Shearer, BG; Stanley, TB; Stimmel, JB; Willson, TM; Xu, HE1
Kaya, T; Sheu, SH; Vajda, S; Waxman, DJ1
Aoyama, T; Hayakawa, M; Ito, Y; Iwabuchi, S; Kozakai, S; Kurita, N; Nakagawa, T; Nakajima, T; Yamaguchi, Y1
Chou, KC; Ma, Y; Wang, RL; Wang, SQ; Xu, WR1
Cano, C; Decara, JM; Fresno, N; Macias-González, M; Pavón, FJ; Pérez-Fernández, R; Rivera, P; Rodríguez de Fonseca, F; Romero-Cuevas, M; Serrano, A; Suárez, J; Vida, M1
Baccei, CS; Bravo, Y; Broadhead, A; Bundey, R; Chen, A; Clark, R; Correa, L; Jacintho, JD; Lorrain, DS; Messmer, D; Prasit, P; Stebbins, K; Stock, N1
Al Sharif, M; Alov, P; Diukendjieva, A; Pajeva, I; Tsakovska, I; Vitcheva, V1

Other Studies

8 other study(ies) available for oxazoles and gw 409544

ArticleYear
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Nov-20, Volume: 98, Issue:24

    Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Oxazoles; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tyrosine

2001
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
    Nature, 2002, Feb-14, Volume: 415, Issue:6873

    Topics: Amino Acid Motifs; Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; DNA-Binding Proteins; Humans; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Sequence Data; Nuclear Receptor Co-Repressor 2; Oxazoles; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Sequence Alignment; Structure-Activity Relationship; Transcription Factors; Tyrosine

2002
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
    Biochemistry, 2005, Feb-01, Volume: 44, Issue:4

    Topics: Alkanesulfonates; Binding Sites; Cinnamates; Computational Biology; Humans; Ligands; Oxazines; Oxazoles; Phenylpropionates; PPAR gamma; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Rosiglitazone; Solvents; Thiazoles; Thiazolidinediones; Thiazolidines; Tyrosine

2005
Molecular mechanics and molecular orbital simulations on specific interactions between peroxisome proliferator-activated receptor PPARalpha and plasticizer.
    Journal of molecular graphics & modelling, 2008, Volume: 27, Issue:1

    Topics: Amino Acid Sequence; Animals; Computer Simulation; Crystallography, X-Ray; Electrons; Esters; Humans; Isomerism; Ligands; Mice; Models, Molecular; Molecular Sequence Data; Oxazoles; Plasticizers; PPAR alpha; Protein Structure, Tertiary; Thermodynamics; Tyrosine

2008
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Binding Sites; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Ligands; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Molecular Structure; Oxazoles; PPAR alpha; PPAR gamma; Protein Structure, Tertiary; Tyrosine

2012
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.
    Disease models & mechanisms, 2012, Volume: 5, Issue:5

    Topics: Adipose Tissue, Brown; Adipose Tissue, White; Amides; Animals; Blood Glucose; Cholesterol; Feeding Behavior; Gene Expression Profiling; Gene Expression Regulation; Glucose Tolerance Test; Humans; Hydrogen Bonding; Insulin; Insulin Resistance; Ligands; Liver; Male; Models, Molecular; Oleic Acids; Oxazoles; PPAR alpha; Protein Binding; Rats; Solutions; Sulfonamides; Taste; Thermogenesis; Tyrosine; Weight Gain

2012
Identification of the first potent, selective and bioavailable PPARα antagonist.
    Bioorganic & medicinal chemistry letters, 2014, May-15, Volume: 24, Issue:10

    Topics: Animals; Butyrates; Humans; Mice; Molecular Structure; Oxazoles; Phenylurea Compounds; PPAR alpha; Propionates; Structure-Activity Relationship; Sulfonamides; Triazoles; Tyrosine

2014
Molecular Modeling Approach to Study the PPARγ-Ligand Interactions.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 1966

    Topics: Humans; Hypoglycemic Agents; Ligands; Molecular Docking Simulation; Oxazoles; PPAR gamma; Protein Conformation; Quantitative Structure-Activity Relationship; Rosiglitazone; Tyrosine

2019